According to Smith & Nephew 's latest financial reports the company's current earnings (TTM) are $0.75 B. a decrease over its 2013 earnings that were of $0.82 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2014 | $0.75 B | -7.78% |
2013 | $0.82 B | -29.42% |
2012 | $1.16 B | 35.58% |
2011 | $0.86 B | -5.81% |
2010 | $0.91 B | 28.23% |
2009 | $0.71 B | 13.02% |
2008 | $0.63 B | 27.79% |
2007 | $0.49 B | -6.63% |
2006 | $0.52 B | 136.13% |
2005 | $0.22 B | -46.19% |
2004 | $0.41 B | 11.34% |
2003 | $0.37 B | |
2001 | -$0.46 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | 2,136.10% | ๐บ๐ธ USA |
Boston Scientific BSX | $1.98 B | 161.53% | ๐บ๐ธ USA |
Edwards Lifesciences EW | $1.61 B | 112.87% | ๐บ๐ธ USA |
Stryker Corporation SYK | $3.67 B | 383.93% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | -$0.15 B | -118.45% | ๐บ๐ธ USA |
CONMED CNMD | $0.12 B | -84.11% | ๐บ๐ธ USA |